Target
Monoglyceride lipase
Ligand
BDBM474449
Substrate
n/a
Meas. Tech.
MAGL Enzymatic Assay (30 minute)
IC50
23.0±n/a nM
Citation
 Brodney, MAButler, CRMcAllister, LAHelal, CJO''Neil, SVVerhoest, PR Heterocyclic spiro compounds as MAGL inhibitors US Patent  US10858373 Publication Date 12/8/2020 
Target
Name:
Monoglyceride lipase
Synonyms:
HU-K5 | Lysophospholipase homolog | Lysophospholipase-like | MAGL | MGL | MGLL | MGLL_HUMAN
Type:
Hydrolase
Mol. Mass.:
33264.56
Organism:
Homo sapiens (Human)
Description:
Human recombinant MGL (Cayman Chemical, cat# 10008354).
Residue:
303
Sequence:
MPEESSPRRTPQSIPYQDLPHLVNADGQYLFCRYWKPTGTPKALIFVSHGAGEHSGRYEELARMLMGLDLLVFAHDHVGHGQSEGERMVVSDFHVFVRDVLQHVDSMQKDYPGLPVFLLGHSMGGAIAILTAAERPGHFAGMVLISPLVLANPESATTFKVLAAKVLNLVLPNLSLGPIDSSVLSRNKTEVDIYNSDPLICRAGLKVCFGIQLLNAVSRVERALPKLTVPFLLLQGSADRLCDSKGAYLLMELAKSQDKTLKIYEGAYHVLHKELPEVTNSVFHEINMWVSQRTATAGTASPP
  
Inhibitor
Name:
BDBM474449
Synonyms:
US10858373, Example 47
Type:
Small organic molecule
Emp. Form.:
C21H27N3O7S
Mol. Mass.:
465.52
SMILES:
CN(C1COC2(C1)CCN(CC2)C(=O)ON1C(=O)CCC1=O)S(=O)(=O)Cc1ccccc1
Structure:
Search PDB for entries with ligand similarity: